National Science Foundation awarded rapid response grants to support coronavirus (COVID-19) research
On Apr. 21, 2020, the National Science Foundation (NSF) issued a letter to researchers inviting proposals for rapid…
Vaxart announced positive preclinical data for ioral COVID-19 vaccine program
On Apr. 21, 2020, Vaxart announced it had obtained positive pre-clinical results for its COVID-19 vaccine candidates, with…
aTyr Pharma announced phase 2 study of ATYR1923 in COVID-19 patients with severe respiratory complications
On Apr. 21, 2020, aTyr Pharma announced the FDA has accepted its Investigational New Drug application to evaluate…
OpGen subsidiary Curetis GmbH and Karolinska Institutet collaborated in study of bacterial Co-infections in COVID-19 pneumonia patients
On Apr. 21, 2020, OpGen announced the start of an investigator initiated collaboration with Karolinska Institutet, Sweden, to…
LabCorp COVID-19 at-home test kit received FDA Emergency Use Authorization
On Apr. 21, 2020, LabCorpﾮ announced it has received an Emergency Use Authorization (EUA) from the FDA. The…
Quest Diagnostics began performing COVID-19 antibody testing
On Apr. 21, 2020, Quest Diagnostics announced that it has begun to perform antibody testing for coronavirus (COVID-19)…
New virus detection process under development at Rutgers-Camden
On Apr. 21, 2020,the fight against the coronavirus is underway in a Rutgers UniversityﾖCamden research laboratory, where chemistry…
Immunic reported that IMU-838 demonstrated Preclinical activity against SARS-CoV-2 and explores plans for phase 2 clinical trial in COVID-19 patients
On Apr. 21, 2020, Immunic reported that its lead asset, IMU-838, a selective oral DHODH inhibitor successfully demonstrated…
Alexion announced plans to initiate phase 3 study of ULTOMIRISﾮ (ravulizumab-cwvz) in hospitalized patients with severe COVID-19
On Apr. 20, 2020, Alexion announced plans to initiate a global Phase 3 study to investigate ULTOMIRISﾮ (ravulizumab-cwvz)…
Screening of 11,552 compounds identified Innovation Pharma’s Brilacidin as promising Potential inhibitors of novel Coronavirus COVID-19
On Apr. 20, 2020, Innovation Pharma reported that based on molecular screening of 11,552 compounds comprising already FDA-approved…
Deison Technology Park provided increased capacity for VGXI to manufacture vaccines
On Apr. 20, 2020, VGX signed as the first occupant of Conroeﾒs Deison Technology Park and will move…
Atossa Therapeutics submitted Clinical Investigation approval to FDA for launch of COVID-19 HOPE study
On Apr. 20, 2020, Atossa Therapeutics announced that it had applied to the FDA for approval to commence…
CDC | COVID-19 | Life Science History | NIH
The NIH launched a public-private partnership to speed COVID-19 vaccine and treatment options
On Apr. 17, 2020, the NIH and the Foundation for the NIH are bringing together more than a…
Emory University Began enrolling older adults in COVID-19 vaccine clinical trial
On Apr. 17, 2020, Emory University announced it had begun enrolling adults over age 55 in the clinical…
Dynavax and Sinovac announced collaboration to develop a Coronavirus (COVID-19) vaccine
On Apr. 16, 2020, Dynavax and Sinovac Biotech, a leading provider of biopharmaceutical products in China, announced a…
Scripps Research expanded international effort to rapidly repurpose existing drugs against COVID-19
On Apr. 16, 2020, Scripps Research announced that researchers at Calibr, Scripp’s drug development division, had established an…
Pulmatrix and Sensory Cloud announced partnership to develop and commercialize nasal prophylactic and anticontagion product for COVID-19
On Apr. 16, 2020, Pulmatrix announced a collaboration and license agreement with Sensory Cloud. Under the terms of…
CHF Solutions announced 300% increase in utilization of Aquadex Therapy in NYC hospitals, the epicenter of COVID-19
On Apr. 16, 2020, CHF Solutions announced increased utilization of its Aquadex therapy in patients affected by COVID-19….
Soligenix announced exclusive licensing agreement for novel vaccine adjuvant from BTG Specialty Pharmaceuticals
On Apr. 16, 2020, Soligenix announced it has executed an agreement for the exclusive worldwide license of CoVaccine…
FDA accepted for Priority Review Biologics License Application for REGN-EB3 to treat Ebola
On Apr. 16, 2020, Regeneron announced the FDA has accepted for Priority Review a new Biologics License Application…
Atossa Therapeutics launched COVID-19 HOPE drug development program
On Apr. 16, 2020, Atossa Therapeutics announced a new drug development program called COVID-19 HOPE. The program used…
Abbott launched third COVID-19 test, a laboratory-based antibody blood test
On Apr. 15, 2020, Abbott announced the launch of its third COVID-19 test, a lab-based serology blood test…
HALIX entered collaboration with University of Oxford for GMP manufacturing of a COVID-19 vaccine
On Apr. 15, 2020, HALIX announced it had joined a consortium of partners under the guidance of the…
Ventilator Manufacturers Group established the Ventilator Training Alliance to help frontline medical workers during pandemic
On Apr. 15, 2020, Getinge announced support of the Ventilator Manufacturers Group to form Ventilator Training Alliance (VTA)…
NIH study validated decontamination methods for re-use of N95 respirators
On Apr. 15, 2020, N95 respirators can be decontaminated effectively and maintain functional integrity for up to three…
Researchers restored sight in mice by turning skin cells into light-sensing eye cells
On Apr. 15, 2020, researchers have discovered a technique for directly reprogramming skin cells into light-sensing rod photoreceptors…
Queensland University announced new mask material made from sugar cane removed virus-size nanoparticles
On Apr. 15, 2020, Queensland University of Technology (QUT) reported it had developed and tested a highly breathable…
Accelerate Diagnostics and BioCheck announced commercial supply and collaboration agreement for SARS-CoV-2 antibody tests
On Apr. 15, 2020, Accelerate Diagnostics announced they have entered into a commercial supply and collaboration agreement. Under…
FDA approved initiation of Humanigen’s phase III study of lenzilumab in COVID-19 patients
On Apr. 15, 2020, Humanigen announced that U.S. Food and Drug Administration (FDA) had given permission to commence…
Philips teamed with University of Kentucky’s UK HealthCare to power state’s only eICU Clinical Command Center
On Apr. 15, 2020, Royal Philips and UK HealthCare, the clinical enterprise of the University of Kentucky, announced…